Lack of beneficial effects of the NO-donor, molsidomine, in the L-NAME-induced pre-eclamptic syndrome in pregnant rats

British Journal of Pharmacology

Volumn 119, Issue 8, 1996, Pages 1642-1648

  Richer, Christine ^a   Boulanger, Henri ^a   Es Slami, Samira ^a   Giudicelli, Jean François ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Foetal outcome; L NAME; Molsidomine; Nitric oxide; Pre eclampsia; Pregnant rats; Vascular presser reactivity

Indexed keywords

ANGIOTENSIN; MOLSIDOMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NORADRENALIN;

ANIMAL EXPERIMENT; ARTICLE; BIRTH WEIGHT; BLOOD VESSEL REACTIVITY; BODY WEIGHT; CONTROLLED STUDY; ELECTROSTIMULATION; FEMALE; FETUS; FETUS RESORPTION; LITTER SIZE; MATERNAL HYPERTENSION; NEWBORN; NONHUMAN; ORAL DRUG ADMINISTRATION; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; SPINAL CORD STIMULATION;

EID: 0030479815     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb16084.x     Document Type: Article

References (30)

1. AZAR, S.H. & SANCHEZ-PENA, S. (1991). Continuous blood pressure monitoring by radio-telemetry during pregnancy and lactation in spontaneously hypertensive and normotensive rats. Clin Exp Hyperten., ed. Part B, 13, 119-122.
2. BAKER, P.N., DAVIDGE, S.T., BARANKIEWICZ, J. & ROBERTS, J.M. (1996). Plasma of preeclamptic women stimulates and then inhibits endothelial prostacyclin. Hypertension, 27, 56-61.
3. BAKER, P.N., DAVIDGE, S.T. & ROBERTS, J.M. (1995). Plasma from women with preeclampsia increases endothelial cell nitric oxide production. Hypertension, 26, 244-248.
4. BÖGER, R.H., BODE-BÖGER, S.M., GERECKE, U. & FRÖLICH, J.C. (1994). Long term administration of L-arginine, L-NAME, and the exogenous NO donor molsidomine modulates urinary nitrate and cGMP excretion in rats. Cardiovasc. Res., 28, 494-499.
5. BUNAG, R.D. & BUTTERFIELD, J. (1982). Tail-cuff blood pressure measurement without external preheating in awake rats. Hypertension, 4, 898-903.
6. BUTLER, A.R., FLITNEY, F.W. & WILLIAMS, D.L.H. (1995). NO. nitrosonium ions, nitroxide ions, nitrosothiols and iron-nitrosyls in biology: a chemist's perspective. Trends Pharmacol. Sci., 16, 18-22.
7. CONRAD, K.P., JOFFE, G.M., KRUSZYNA, H., KRUSZYNA, R., ROCHELLE, L.G., SMITH, R.P., CHAVEZ, J.E. & MOSHER, M.D. (1993). Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J., 7, 566-571.
8. DELACRETAZ, E., DE QUAY, N., WAEBER, B., VIAL, Y., SCHULZ, P.E., BURNIER, M., BRUNNER, H.R., BOSSART, H. & SCHAAD, N.C. (1995). Differential nitric oxide synthase activity in human platelets during normal pregnancy and pre-eclampsia. Clin. Sci., 88, 607-610.
9. DESIMONE, C.A., LEIGHTON, B.I., NORRIS, M.C., CHAYEN, B. & MENDUKE, H. (1988). The chronotropic effect of isoproterenol is reduced in term pregnant women. Anesthesiology, 69, 626-628.
10. FEELISCH, M., OSTROWSKI, J. & NOACK, E. (1989). On the mechanism of NO release from sydnonimines. J. Cardiovasc. Pharmacol., 14(Suppl. 11), S13-S22.
11. FICKLING, S.A., WILLIAMS, D., VALLANCE, P., NUSSEY, S.S. & WHITLEY, G.St.J. (1993). Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and preeclampsia. Lancet, 342, 242-243.
12. GANT, N.F., DALEY, G.I., CHAND, S., WHALLEY, P.J. & MCDONALD, P.C. (1987). Control of vascular reactivity in pregnancy. Am. J. Clin. Invest., 52, 2682-2689.
13. GOETZ, R.M., MORANO, I., CALOVINI, T., STUDER, R. & HOLTZ, J.(1994). Increased expression of endothelial constitutive nitric oxide synthase in rat aorta during pregnancy. Biochem. Biophys. Res. Commun., 205, 905-910.
14. KUHN, M. & FORSTERMANN, U. (1989). Endothelium-dependent vasodilatation in human epicardial coronary arteries: effect of prolonged exposure to glyceryl trinitrate or SIN-1. J. Cardiovasc. Pharmacol., 14(Suppl. 11), S47-S54.
15. LUDBROOK, J. (1994). Repeated measurements and multiple comparisons in cardiovascular research, Cardiovasc. Res., 28, 303-311.
16. MOLNAR, M. & HERTELENDY, F. (1992). N-Nitro-L-arginine, an inhibitor of nitric oxide synthesis, increases blood pressure in rats and reverses the pregnancy-induced refractoriness to vasopressor agents. Am. J. Obstet. Gynecol., 166, 1560-1567.
17. MOLNAR, M., SÜTÖ, T., TOTH, T. & HERTELENDY, F. (1994). Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am. J. Obstet. Gynecol., 170, 1458-1466.
18. MYATT, L., BREWER, A. & BROCKMAN, D.E. (1991). The action of nitric oxide in the perfused human fetal-placental circulation. Am. J. Obstet. Gynecol., 164, 687-692.
19. NATHAN, L., CUEVAS, J. & CHAUDHURI, G. (1995). The role of nitric oxide in the altered vascular reactivity of pregnancy in the rat. Br. J. Pharmacol., 114, 955-960.
20. PINTO, A., SORRENTINO, R., SAUTEBIN, L., MIRANDA, L. & SORRENTINO, P. (1992). Identification and partial purification of an endothelium-derived relaxing factor inhibitor in serum of hypertensive preeclamptic parturients. In Biology of Nitric Oxide. pp. 373-376. London: Portland Press.
21. PINTO, A., SORRENTINO, R., SORRENTINO, P., GUERRITORE, T., MIRANDA, L., BIONDI, A. & MARTINELLI, P. (1991). Endothelial-derived relaxing factor released by endothelial cells of human umbilical vessels and its impairment in pregnancy-induced hypertension. Am. J. Obstet. Gynecol., 164, 507-513.
22. RAMSAY, B., DE BELDER, A., CAMPBELL, S., MONCADA, S & MARTIN, J.F. (1994). A nitric oxide donor improves uterine artery diastolic blood flow in normal early pregnancy and in women at high risk of pre-eclampsia. Eur. J. Clin. Invest., 24, 76-78.
23. ROBERTS, J.M., TAYLOR, R.N. & GOLDFIEN, A. (1991). Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am. J. Hypertens., 4, 700-708.
24. RUTHERFORD, R.A.D., MCCARTHY, A., SULLIVAN, M.H.F., ELDER, M.G., POLAK, J.M. & WHARTON, J. (1995). Nitric oxide synthase in human placenta and umbilical cord from normal, intrauterine growth-retarded and pre-eclamptic pregnancies. Br. J. Pharmacol., 116, 3099-3109.
25. SALAS, S.P., ALTERMATT, F., CAMPOS, M., GIACAMAN, A. & ROSSO, P. (1995). Effects of long-term nitric oxide synthesis inhibition on plasma volume expansion and fetal growth in the pregnant rat. Hypertension, 26, 1019-1023.
26. SELIGMAN, S.P., BUYON, J.P., CLANCY, R.M., YOUNG, B.K. & ABRAMSON, S.B. (1994). The role of nitric oxide in the pathogenesis of preeclampsia. Am. J. Obstet. Gynecol., 171, 944-948.
27. SHAN, J., RESNICK, L.M., LIU, Q.Y., WU, X.C., BARBAGALLO, M. & PANG, P.K.T. (1994). Vascular effects of 170-estradiol in male Sprague-Dawley rats. Am. J. Physiol., 266, H967-H973.
28. VENUTO, R., MIN, I., BARONE, P., DONKER, A. & CUNNINGHAM, E. (1984). Blood pressure control in pregnant rabbits: norepinephrine and prostaglandin interactions. Am. J. Physiol., 247, R786-R791.
29. WEINER, C.P., LIZASOAIN, I., BAYLIS, S.A., KNOWLES, R.G., CHARLES, I.G. & MONCADA, S. (1994). Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc. Natl. Acad. Sci. U.S.A., 91, 5212-5216.
30. YALLAMPALLI, C. & GARFIELD, R.E. (1993). Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am. J. Obstet. Gynecol., 169, 1316-1320.